GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (NSE:NECLIFE) » Definitions » Pre-Tax Income

Nectar Lifesciences (NSE:NECLIFE) Pre-Tax Income : ₹183 Mil (TTM As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nectar Lifesciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Nectar Lifesciences's pretax income for the three months ended in Mar. 2024 was ₹111 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹183 Mil. Nectar Lifesciences's pretax margin was 2.53%.

During the past 13 years, Nectar Lifesciences's highest Pretax Margin was 5.16%. The lowest was -5.49%. And the median was 2.08%.


Nectar Lifesciences Pre-Tax Income Historical Data

The historical data trend for Nectar Lifesciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nectar Lifesciences Pre-Tax Income Chart

Nectar Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 374.71 -847.67 340.80 -424.20 182.69

Nectar Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.64 30.58 16.42 24.57 111.13

Competitive Comparison of Nectar Lifesciences's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nectar Lifesciences's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Nectar Lifesciences's Pre-Tax Income falls into.



Nectar Lifesciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Nectar Lifesciences's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=923.806+0+-871.417+0+130.3
=183

Nectar Lifesciences's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=338.036+0+-241.595+0+14.684
=111

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹183 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nectar Lifesciences  (NSE:NECLIFE) Pre-Tax Income Explanation

Nectar Lifesciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=111.125/4398.475
=2.53%

During the past 13 years, Nectar Lifesciences's highest Pretax Margin was 5.16%. The lowest was -5.49%. And the median was 2.08%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nectar Lifesciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Nectar Lifesciences (NSE:NECLIFE) Business Description

Traded in Other Exchanges
Address
SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences (NSE:NECLIFE) Headlines

No Headlines